As of April 16, 2025, Omeros Corporation (OMER) has a market cap of $0.40 billion USD. According to our data, Omeros Corporation is ranked No.6203 in global market value.
Year | Market Cap | %Change |
---|---|---|
Apr 16, 2025 | $0.40 B |
-30.33%
|
Dec 31, 2024 | $0.57 B |
202.14%
|
Dec 29, 2023 | $0.19 B |
44.69%
|
Dec 30, 2022 | $0.13 B |
-64.85%
|
Dec 31, 2021 | $0.37 B |
-55.00%
|
Dec 31, 2020 | $0.83 B |
1.42%
|
Dec 31, 2019 | $0.82 B |
26.48%
|
Dec 31, 2018 | $0.65 B |
-42.67%
|
Dec 29, 2017 | $1.13 B |
95.87%
|
Dec 30, 2016 | $0.57 B |
-36.94%
|
Dec 31, 2015 | $0.91 B |
-36.52%
|
Dec 31, 2014 | $1.44 B |
119.49%
|
Dec 31, 2013 | $0.65 B |
117.53%
|
Dec 31, 2012 | $0.30 B |
31.39%
|
Dec 30, 2011 | $0.23 B |
-52.06%
|
Dec 31, 2010 | $0.48 B |
17.38%
|
Dec 31, 2009 | $0.41 B |
100%
|
Name | Market Cap | Market cap difference | Regions |
---|---|---|---|
![]() Amgen
AMGN
|
$158.77 B |
0.132 B
|
![]() USA
|
![]() Biogen
BIIB
|
$17.12 B |
0.000 M
|
![]() USA
|
![]() Gilead Sciences
GILD
|
$131.74 B |
-0.002 M
|
![]() USA
|
![]() Regeneron Pharmaceuticals
REGN
|
$60.99 B |
1.014 B
|
![]() USA
|
![]() Vertex Pharmaceuticals
VRTX
|
$128.67 B |
-0.003 M
|
![]() USA
|
![]() Incyte
INCY
|
$11.31 B |
0.000 M
|
![]() USA
|
![]() BioMarin Pharmaceutical
BMRN
|
$11.51 B |
-0.000 M
|
![]() USA
|
![]() Sarepta Therapeutics
SRPT
|
$5.28 B |
-0.000 M
|
![]() USA
|
![]() Alnylam Pharmaceuticals
ALNY
|
$29.89 B |
-0.001 M
|
![]() USA
|
![]() Ionis Pharmaceuticals
IONS
|
$4.51 B |
0.000 M
|
![]() USA
|
![]() Moderna
MRNA
|
$10.14 B |
-0.001 M
|
![]() USA
|
![]() Novavax
NVAX
|
$1.03 B |
0.000 M
|
![]() USA
|
![]() bluebird bio
BLUE
|
$43.76 M |
0.000 M
|
![]() USA
|
![]() CRISPR Therapeutics
CRSP
|
$3.34 B |
0.000 M
|
![]() Switzerland
|
Market Cap | = | OMER Stock Price | * | OMER Shares Outstanding |
= | $6.87 | * | 58.06 M | |
= | $0.40 B |